Nirogmaya Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 7.10 M
- Paid Up Capital ₹ 6.70 M
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 2.91 Cr
- Revenue Growth %
- Profit Growth 23.96%
- Ebitda
- Net Worth -10.88%
- Total Assets %
About Nirogmaya Lifesciences
Nirogmaya Lifesciences Limited (NLL) is a Public Limited Indian Non-Government Company incorporated in India on 20 August 2008 and has a history of 16 years and five months. Its registered office is in Panchkula, Haryana, India.
The Corporate was formerly known as Oirpil Biotech Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 7.10 M and a paid-up capital of Rs 6.70 M.
The company has closed loans amounting to ₹2.91 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Abhishek Goyal, Vijay Kumar, and Aakanksha Sharma serve as directors at the Company.
Company Details
-
Location
Panchkula, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24119CH2008PLC031331
-
Company No.
031331
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
20 Aug 2008
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Nirogmaya Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Goyal
|
Director | 13-Mar-2019 | Current |
|
Vijay Kumar
|
Additional Director | 23-Jul-2024 | Current |
|
Aakanksha Sharma
|
Director | 21-Jul-2023 | Current |
Financial Performance of Nirogmaya Lifesciences.
Nirogmaya Lifesciences Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 23.96% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirogmaya Lifesciences?
In 2018, Nirogmaya Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Blyss Insurance Marketing Private LimitedAbhishek Goyal is a mutual person
-
Xtream Concepts And Ventures Private Limited
Vijay Kumar is a mutual person
Charges (Loans)
₹0
₹29.09 M
Charges Breakdown by Lending Institutions
- Punjab & Sindh Bank : 2.37 Cr
- State Bank Of India : 0.35 Cr
- Punjab & Sind Bank : 0.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jul 2011 | Punjab & Sind Bank | ₹1.89 M | Satisfied |
| 22 Jul 2011 | Punjab & Sindh Bank | ₹2.37 Cr | Satisfied |
| 03 Mar 2009 | State Bank Of India | ₹3.50 M | Satisfied |
How Many Employees Work at Nirogmaya Lifesciences?
Unlock and access historical data on people associated with Nirogmaya Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirogmaya Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirogmaya Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
